Cas:207399-16-4 sodium,2,3-dioxo-1H-indole-5-sulfonate,dihydrate manufacturer & supplier

We serve Chemical Name:sodium,2,3-dioxo-1H-indole-5-sulfonate,dihydrate CAS:207399-16-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

sodium,2,3-dioxo-1H-indole-5-sulfonate,dihydrate

Chemical Name:sodium,2,3-dioxo-1H-indole-5-sulfonate,dihydrate
CAS.NO:207399-16-4
Synonyms:Isatin-5-sulfonic acid sodium salt dihydrate;Sodium isatin-5-sulfonate dihydrate
Molecular Formula:C8H8NNaO7S
Molecular Weight:285.20600
HS Code:2933990090

Physical and Chemical Properties:
Melting point:≥300ºC(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:130.21000
Exact Mass:284.99200
LogP:0.81570

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like Isatin-5-sulfonic acid sodium salt dihydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sodium isatin-5-sulfonate dihydrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Isatin-5-sulfonic acid sodium salt dihydrate Use and application,Sodium isatin-5-sulfonate dihydrate technical grade,usp/ep/jp grade.


Related News: This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire. sodium,2,3-dioxo-1H-indole-5-sulfonate,dihydrate manufacturer But even though weight-loss success depends on adopting a challenging” change in post-operation diet and lifestyle, the process can certainly “help people to lose weight and get comorbid [other negative health] conditions under better control,” Sandon said.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies. sodium,2,3-dioxo-1H-indole-5-sulfonate,dihydrate supplier The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15. sodium,2,3-dioxo-1H-indole-5-sulfonate,dihydrate vendor This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire. sodium,2,3-dioxo-1H-indole-5-sulfonate,dihydrate factory But even though weight-loss success depends on adopting a challenging” change in post-operation diet and lifestyle, the process can certainly “help people to lose weight and get comorbid [other negative health] conditions under better control,” Sandon said.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies.